Stay updated on HMPL-523 in Lymphoma Patients Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.

Latest updates to the HMPL-523 in Lymphoma Patients Clinical Trial page
- Check6 days agoChange DetectedAdded 'Results Posted' and new site details including Bergamo, Italy. Expanded Dose Escalation and Dose Expansion sections with detailed study endpoint definitions (PFS, TTR, DOR, ORR, CBR) and scheduling; removed older endpoint descriptions and some prior location text.SummaryDifference5%

- Check13 days agoChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1. This appears to be a minor site maintenance update and does not alter the study details or user-facing content.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe changes largely consist of cosmetic UI text adjustments and a new revision/version indicator (v3.4.0) replacing the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. This change is a metadata update and does not modify study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedResults status updated to 'Results Submitted' and new site locations added (California, New Jersey, New York, North Carolina, Texas, Milano), with the page revision noted as v3.3.3.SummaryDifference0.7%

Stay in the know with updates to HMPL-523 in Lymphoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.